Atypical pneumonia: recognition and treatment

Area of Science:

• Infectious Diseases
• Pulmonology
• Clinical Microbiology

Background:

• The term 'atypical pneumonia' is clinically useful for guiding empirical antibiotic therapy.
• It describes a common syndrome, though not strictly definable.
• Understanding common causative agents is crucial for effective treatment.

Purpose of the Study:

• To emphasize the clinical utility of the term 'atypical pneumonia'.
• To identify the most common infectious agents causing this syndrome.
• To discuss the antimicrobial therapy for prevalent causes of atypical pneumonia.

Main Methods:

• Clinical and epidemiological review of 'atypical pneumonia' syndrome.
• Identification of common causative microorganisms.
• Detailed discussion of antimicrobial treatment strategies.

Main Results:

• Mycoplasma pneumoniae, Chlamydia psittaci, Coxiella burneti, and Legionella species are the most frequent infectious causes.
• The syndrome can occasionally result from other infectious or non-infectious diseases.
• The clinical spectrum of these organisms extends beyond the 'atypical pneumonia' syndrome.

Conclusions:

• The term 'atypical pneumonia' remains a valuable clinical descriptor for guiding initial antibiotic selection.
• Knowledge of specific causative agents and their broader disease spectrum is essential for optimizing therapy, especially in severe cases.
• Antimicrobial therapy for common causes like Mycoplasma pneumoniae is detailed.